PubMed ID:
32058554
Public Release Type:
Journal
Publication Year: 2020
Affiliation: Department of Paediatric Nephrology, Royal Hospital for Children, Glasgow, United Kingdom.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Division of Nephrology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.; Department of Pediatrics, University of Washington, Seattle.; Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Division of Pediatric Nephrology, Children's Mercy Kansas City, Kansas City, Missouri.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
DOI:
https://doi.org/10.1001/jamanetworkopen.2019.21213
Authors:
Reynolds Ben Christopher, Roem Jennifer Lynn, Ng Derek Kai Sing, Matsuda-Abedini Mina, Flynn Joseph Thomas, Furth Susan Lynn, Warady Bradley Alan, Parekh Rulan Savita
Request IDs:
20588
Studies:
The Chronic Kidney Disease in Children Cohort Study
Optimal blood pressure (BP) management in children with chronic kidney disease (CKD) slows progression to end-stage renal disease. Studies often base progression risk on a single baseline BP measurement, which may underestimate risk.